Abstract
The research on protein deimination and the enzymes responsible for catalyzing this posttranslational modification started from investigations of the hair follicle and myelin in central nerve system. About 60 years ago, in 1958, the presence of protein-bound citrulline was first reported by Dr. George Rogers (Adelaide University, Australia) in the protein of the inner root sheath (IRS) of hair follicles (Rogers 1958). In order to obtain information about the protein composition of the IRS, he conducted a quantitative amino acid analysis of an acid hydrolysate on sufficient amounts of IRS that were dissected from the vibrissae follicle of rats. At that time, the common method for separating amino acids was paper chromatography, and when applied to the IRS hydrolysates, citrulline was discovered as a distinct ninhydrin-positive spot in an area adjacent to the basic amino acids. About 10 years after Rogers’s discovery, Dr. Mario Moscarello (Toronto University, Canada) started an intensive investigation of myelin sheath proteins in the central nerve system. In 1971, he also found the presence of peptide-bound citrulline in myelin basic protein (MBP) using similar methods to Rogers (Finch et al. 1971). Moscarello continued the investigation of MBP until he passed away in 2013, publishing many papers concerning the hyper-deimination of MBP in the pathology of multiple sclerosis. His research career involving the deimination of MBP was described in a eulogy in the first volume of this book series (Nicholas and Bhattacharya 2014).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Arita, K., et al. (2004). Structural basis for Ca(2+)-induced activation of human PAD4. Nature Structural & Molecular Biology, 11(8), 777–783.
Asaga, H., Yamada, M., & Senshu, T. (1998). Selective deimination of vimentin in calcium ionophore-induced apoptosis of mouse peritoneal macrophages. Biochemical and Biophysical Research Communications, 243(3), 641–646.
Chavanas, S., et al. (2004). Comparative analysis of the mouse and human peptidylarginine deiminase gene clusters reveals highly conserved non-coding segments and a new human gene, PADI6. Gene, 330, 19–27.
Finch, P. R., Wood, D. D., & Moscarello, M. A. (1971). The presence of citrulline in a myelin protein fraction. FEBS Letters, 15(2), 145–148.
Fujisaki, M., & Sugawara, K. (1981). Properties of peptidylarginine deiminase from the epidermis of newborn rats. Journal of Biochemistry, 89(1), 257–263.
Girbal-Neuhauser, E., et al. (1999). The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues. Journal of Immunology, 162(1), 585–594.
Guerrin, M., Ishigami, A., Mechin, M. C., Nachat, R., Valmary, S., Sebbag, M., Simon, M., Senshu, T., & Serre, G. (2003). cDNA cloning, gene organization and expression analysis of human peptidylarginine deiminase type I. Biochemical Journal, 370(Pt 1), 167–174.
Hsu, P. C., et al. (2014). Vimentin is involved in peptidylarginine deiminase 2-induced apoptosis of activated Jurkat cells. Molecules and Cells, 37(5), 426–434.
Inagaki, M., et al. (1989). Ca2+-dependent deimination-induced disassembly of intermediate filaments involves specific modification of the amino-terminal head domain. The Journal of Biological Chemistry, 264(30), 18119–18127.
Ishigami, A., et al. (1998). Molecular cloning of two novel types of peptidylarginine deiminase cDNAs from retinoic acid-treated culture of a newborn rat keratinocyte cell line. FEBS Letters, 433(1–2), 113–118.
Ishigami, A., et al. (2002). Human peptidylarginine deiminase type II: Molecular cloning, gene organization, and expression in human skin. Archives of Biochemistry and Biophysics, 407(1), 25–31.
Ishigami, A., et al. (2005). Abnormal accumulation of citrullinated proteins catalyzed by peptidylarginine deiminase in hippocampal extracts from patients with Alzheimer’s disease. Journal of Neuroscience Research, 80(1), 120–128.
Kanno, T., et al. (2000). Human peptidylarginine deiminase type III: Molecular cloning and nucleotide sequence of the cDNA, properties of the recombinant enzyme, and immunohistochemical localization in human skin. The Journal of Investigative Dermatology, 115(5), 813–823.
Masson-Bessière, C., et al. (2001). The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin. Journal of Immunology, 166(6), 4177–4184.
Nakashima, K., et al. (1999). Molecular characterization of peptidylarginine deiminase in HL-60 cells induced by retinoic acid and 1alpha,25-dihydroxyvitamin D(3). The Journal of Biological Chemistry, 274(39), 27786–27792.
Nakashima, K., Hagiwara, T., & Yamada, M. (2002). Nuclear localization of peptidylarginine deiminase V and histone deimination in granulocytes. The Journal of Biological Chemistry, 277(51), 49562–49568.
Nicholas, A. P., & Bhattacharya, S. K. (Eds.). (2014). Protein deimination in human health and disease. New York: Springer.
Nishijyo, T., et al. (1997). Isolation and molecular cloning of epidermal- and hair follicle-specific peptidylarginine deiminase (type III) from rat. Journal of Biochemistry, 121(5), 868–875.
Ohsugi, I., et al. (1995). Expression of mouse uterine peptidylarginine deiminase in Escherichia coli: Construction of expression plasmid and properties of the recombinant enzyme. Archives of Biochemistry and Biophysics, 317(1), 62–68.
Rogers, G. E. (1958). Some observations on the proteins of the inner root sheath cells of hair follicles. Biochimica et Biophysica Acta, 29(1), 33–43.
Rogers, G. E., Harding, H. W., & Llewellyn-Smith, I. J. (1977). The origin of citrulline-containing proteins in the hair follicle and the chemical nature of trichohyalin, an intracellular precursor. Biochimica et Biophysica Acta, 495(1), 159–175.
Rus’d, A. A., et al. (1999). Molecular cloning of cDNAs of mouse peptidylarginine deiminase type I, type III and type IV, and the expression pattern of type I in mouse. European Journal of Biochemistry, 259(3), 660–669.
Senshu, T., et al. (1989). Peptidylarginine deiminase in rat pituitary: Sex difference, estrous cycle-related changes, and estrogen dependence. Endocrinology, 124(6), 2666–2670.
Senshu, T., et al. (1992). Detection of citrulline residues in deiminated proteins on polyvinylidene difluoride membrane. Analytical Biochemistry, 203(1), 94–100.
Senshu, T., et al. (1995). Detection of deiminated proteins in rat skin: Probing with a monospecific antibody after modification of citrulline residues. The Journal of Investigative Dermatology, 105(2), 163–169.
Sugawara, K. (1979). Presence of citrulline in the membranous proteins of stratum corneum of newborn rat and cow snout. Agricultural and Biological Chemistry, 43(12), 2215–2217.
Suzuki, A., et al. (2003). Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nature Genetics, 34(4), 395–402.
Takahara, H., Oikawa, Y., & Sugawara, K. (1983). Purification and characterization of peptidylarginine deiminase from rabbit skeletal muscle. Journal of Biochemistry, 94(6), 1945–1953.
Takahara, H., Okamoto, H., & Sugawara, K. (1985). Specific modification of the functional arginine residue in soybean trypsin inhibitor (Kunitz) by peptidylarginine deiminase. The Journal of Biological Chemistry, 260(14), 8378–8383.
Takahara, H., Okamoto, H., & Sugawara, K. (1986). Affinity chromatography of peptidylarginine deiminase from rabbit skeletal muscle on a column of soybean trypsin inhibitor (Kunitz)-Sepharose. Journal of Biochemistry, 99(5), 1417–1424.
Takahara, H., et al. (1989). Peptidylarginine deiminase of the mouse. Distribution, properties, and immunocytochemical localization. The Journal of Biological Chemistry, 264(22), 13361–13368.
Takahara, H., et al. (1992). Expression of peptidylarginine deiminase in the uterine epithelial cells of mouse is dependent on estrogen. The Journal of Biological Chemistry, 267(1), 520–525.
Terakawa, H., Takahara, H., & Sugawara, K. (1991). Three types of mouse peptidylarginine deiminase: Characterization and tissue distribution. Journal of Biochemistry, 110(4), 661–666.
Tsuchida, M., et al. (1993). cDNA nucleotide sequence and primary structure of mouse uterine peptidylarginine deiminase. Detection of a 3′-untranslated nucleotide sequence common to the mRNA of transiently expressed genes and rapid turnover of this enzyme’s mRNA in the estrous cycle. European Journal of Biochemistry, 215(3), 677–685.
Watanabe, K., & Senshu, T. (1989). Isolation and characterization of cDNA clones encoding rat skeletal muscle peptidylarginine deiminase. The Journal of Biological Chemistry, 264(26), 15255–15260.
Watanabe, K., et al. (1988). Combined biochemical and immunochemical comparison of peptidylarginine deiminases present in various tissues. Biochimica et Biophysica Acta, 966(3), 375–383.
Wright, P. W., et al. (2003). ePAD, an oocyte and early embryo-abundant peptidylarginine deiminase-like protein that localizes to egg cytoplasmic sheets. Developmental Biology, 256(1), 73–88.
Yamakoshi, A., et al. (1998). Cloning of cDNA encoding a novel isoform (type IV) of peptidylarginine deiminase from rat epidermis. Biochimica et Biophysica Acta, 1386(1), 227–232.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Takahara, H. (2017). A History of Deimination Research in Japan: The Founding Fathers. In: Nicholas, A., Bhattacharya, S., Thompson, P. (eds) Protein Deimination in Human Health and Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-58244-3_1
Download citation
DOI: https://doi.org/10.1007/978-3-319-58244-3_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-58243-6
Online ISBN: 978-3-319-58244-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)